Literature DB >> 25028191

Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53.

Z-G Shi1, S-Q Li, Z-J Li, X-J Zhu, P Xu, G Liu.   

Abstract

PURPOSE: This study focuses on investigating the expression correlation of vimentin, survivin and p53 in clear cell renal cell carcinoma (ccRCC) and the clinical significance.
METHODS: The mRNA and protein expression levels of the vimentin, survivin and p53 were determined in ccRCC and adjacent normal renal tissues, using quantitative real-time-polymerase chain reaction (qRT-PCR) and Western blot. We detected the expression and localization of vimentin, survivin and p53 protein in ccRCC by immunohistochemistrical SP method and analyzed the relationships among clinical pathologic parameters and patient prognosis.
RESULTS: The expression of vimentin and survivin was significantly increased in ccRCC compared with adjacent normal renal tissues, which were positively correlated with the pathological grade and clinical stage (P < 0.05). p53 was highly expressed in ccRCC compared with normal tissues (P < 0.05), which was not positively correlated with the pathological grade and clinical stage (P > 0.05). Furthermore, univariate and multivariate analysis showed that high expression levels of vimentin and survivin were independent prognostic indicators for ccRCC. The levels of vimentin and survivin were positively correlated in ccRCC (r = 0.428, P < 0.01).
CONCLUSIONS: Reliable basis about biological behavior and prognosis judgments of ccRCC can be provided by combining detection of vimentin and survivin. Foundation and new ideas for gene therapy of ccRCC may be provided by further studying the relationship among vimentin, survivin and p53 in ccRCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25028191     DOI: 10.1007/s12094-014-1199-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  38 in total

Review 1.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

2.  Differentiation plasticity regulated by TGF-beta family proteins in development and disease.

Authors:  Rik Derynck; Rosemary J Akhurst
Journal:  Nat Cell Biol       Date:  2007-09       Impact factor: 28.824

Review 3.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 4.  Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies.

Authors:  I Goldstein; V Marcel; M Olivier; M Oren; V Rotter; P Hainaut
Journal:  Cancer Gene Ther       Date:  2010-10-22       Impact factor: 5.987

5.  Survivin and EPR-1 expression in acute leukemias: prognostic significance and review of the literature.

Authors:  Ozgur Akin Oto; Semra Paydas; Kahraman Tanriverdi; Gulsah Seydaoglu; Sinan Yavuz; Umut Disel
Journal:  Leuk Res       Date:  2007-02-27       Impact factor: 3.156

6.  Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis.

Authors:  Jeong Seok Hwa; Hyo Jin Park; Jae Hun Jung; Sung Chul Kam; Hyung Chul Park; Choong Won Kim; Kee Ryeon Kang; Jea Seog Hyun; Ky Hyun Chung
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

7.  Desmin and vimentin intermediate filament networks: their viscoelastic properties investigated by mechanical rheometry.

Authors:  Michael Schopferer; Harald Bär; Bernhard Hochstein; Sarika Sharma; Norbert Mücke; Harald Herrmann; Norbert Willenbacher
Journal:  J Mol Biol       Date:  2009-03-10       Impact factor: 5.469

8.  CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.

Authors:  Ariel A Williams; John P T Higgins; Hongjuan Zhao; Börje Ljunberg; James D Brooks
Journal:  BMC Clin Pathol       Date:  2009-11-18

9.  Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma.

Authors:  Xing Yao; Xiang Wang; Zishu Wang; Licheng Dai; Guolei Zhang; Qiang Yan; Weimin Zhou
Journal:  Onco Targets Ther       Date:  2012-10-12       Impact factor: 4.147

Review 10.  The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

Authors:  A J Levine; M E Perry; A Chang; A Silver; D Dittmer; M Wu; D Welsh
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  12 in total

1.  [Coexpression of MAP2K4 and vimentin proteins in human endometrial carcinoma and its clinicopathological significance].

Authors:  Chun-Hua Liu; Qing-Ping Jiang; Dan Lin; Wei Chen; Yan-Yi Xiao; Li Lin; Yuan-Run Deng; Hui-Ping Jiang; Sui-Qun Guo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

Review 2.  Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

Authors:  Marina O Golovastova; Dmitry O Korolev; Larisa V Tsoy; Vladimir A Varshavsky; Wan-Hai Xu; Andrey Z Vinarov; Evgeni Yu Zernii; Pavel P Philippov; Andrey A Zamyatnin
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

Review 3.  Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Yongpeng Xie; Xin Ma; Liangyou Gu; Hongzhao Li; Luyao Chen; Xintao Li; Yu Gao; Yang Fan; Yu Zhang; Yuanxin Yao; Xu Zhang
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

4.  Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis.

Authors:  Zhun Wang; Shuanghe Peng; Ning Jiang; Aixiang Wang; Shuguang Liu; Hui Xie; Linpei Guo; Qiliang Cai; Yuanjie Niu
Journal:  Oncotarget       Date:  2017-10-19

5.  Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.

Authors:  Zhichen Pu; Qifei Wang; Haitang Xie; Guangji Wang; Haiping Hao
Journal:  Oncotarget       Date:  2017-03-21

6.  Fibronectin Promotes Cell Growth and Migration in Human Renal Cell Carcinoma Cells.

Authors:  Yen-Chuan Ou; Jian-Ri Li; Jiaan-Der Wang; Cheng-Yi Chang; Chih-Cheng Wu; Wen-Ying Chen; Yu-Hsiang Kuan; Su-Lan Liao; Hsi-Chi Lu; Chun-Jung Chen
Journal:  Int J Mol Sci       Date:  2019-06-07       Impact factor: 5.923

7.  Vimentin Overexpressions Induced by Cell Hypoxia Promote Vasculogenic Mimicry by Renal Cell Carcinoma Cells.

Authors:  Hao Lin; Yingkai Hong; Bin Huang; Xincheng Liu; Junhong Zheng; Shaopeng Qiu
Journal:  Biomed Res Int       Date:  2019-07-21       Impact factor: 3.411

8.  Development of an Autophagy-Related Gene Prognostic Model and Nomogram for Estimating Renal Clear Cell Carcinoma Survival.

Authors:  Ying Wang; Yinhui Yao; Jingyi Zhao; Chunhua Cai; Junhui Hu; Yanwu Zhao
Journal:  J Oncol       Date:  2021-02-18       Impact factor: 4.375

9.  Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.

Authors:  Yang Yang; Jianjun Xu; Qingyun Zhang
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

10.  Influence of gene expression on survival of clear cell renal cell carcinoma.

Authors:  Anders Berglund; Ernest K Amankwah; Young-Chul Kim; Philippe E Spiess; Wade J Sexton; Brandon Manley; Hyun Y Park; Liang Wang; Jad Chahoud; Ratna Chakrabarti; Chang D Yeo; Hung N Luu; Giuliano D Pietro; Alexander Parker; Jong Y Park
Journal:  Cancer Med       Date:  2020-09-28       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.